RobertS.Copeland-HalperinMDFACC

Nuclear Cardiology, Non-Invasive Cardiology, Vascular Medicine

Director of Cardio-Oncology, Northwell Health System

Overview of Dr. Copeland-Halperin

Fellowship trained Cardio-Oncologist specializing the Cardiovascular Care of Patients with Cancer.
Member ACC Cardio-Oncology Leadership Council

Memorial Sloan Kettering Cancer CenterFellow, Cardio-Oncology, Cardio-Oncology, 2019 - 2020
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2016 - 2019
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2013 - 2016
Icahn School of Medicine at Mount SinaiClass of 2013
Hamilton CollegeB.A., Psychology, Psi Chi Honor Society, 2001 - 2005

Fellow of the American College of Cardiology American College of Cardiology, 2020
Alpha Omega Alpha Icahn School of Medicine at Mount Sinai, 2014
Gold Humanism Honor Society Icahn School of Medicine at Mount Sinai, 2013

PubMed

60 citations
Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer-generation DES: Findings from a large multiethnic registry
Robert Copeland-Halperin, Usman Baber, Melissa Aquino, Anitha Rajamanickam, Swathi Roy
Catheterization and Cardiovascular Interventions. 2018-04-01
31 citations
Cardiotoxicity of HER2-targeted therapies.
Robert S Copeland-Halperin, Jennifer E. Liu, Anthony F. Yu
Current Opinion in Cardiology. 2019-07-01
23 citations
Impaired Skeletal Muscle Glucose Uptake by [18F]Fluorodeoxyglucose–Positron Emission Tomography in Patients With Peripheral Artery Disease and Intermittent Claudication
Reena L. Pande, Mi-Ae Park, Todd S. Perlstein, Akshay S. Desai, Jeanne Doyle
Arteriosclerosis, Thrombosis, and Vascular Biology. 2011-01-01

Atlas of Imaging in Cardio Oncology: Cardio-Oncology in the COVID-19 EraAugust 2021

Research AssistantCardiovascular Division Vascular Medicine Section Brigham and Women's Hospital Boston, MA2007 - 2009